Literature DB >> 11741203

A short term (accelerated release) approach to evaluate peptide release from PLGA depot-formulations.

M Shameem1, H Lee, P P DeLuca.   

Abstract

An accelerated method to evaluate peptide release from poly(dl-lactide-co-glycolide) (PLGA) depot formulations in short time is described. Peptide-loaded microspheres were made from hydrophilic 50:50 PLGA by a dispersion-solvent extraction technique, and peptide release was studied at 37 degrees C and at higher temperatures in various media. For all accelerated conditions, release was faster at temperatures above the glass transition, Tg, of the host polymer. Complete release of peptide from 8600 MW PLGA was achieved in 35 hours at 50 degrees C in buffered and nonbuffered media containing 0.5% polyvinyl alcohol (PVA). Type of release media and concentration of PVA influenced the release profiles. A PVA concentration of 0.1 to 0.5% was found to prevent aggregation of microspheres at higher temperatures, with an increase in release at the higher PVA concentration. Peptide release was associated with a reduction of pH of the releasing media and increased mass loss. Complete peptide release at pH 4 from 8.6 kd and 28 kd PLGA at 50 and 60 degrees C occurred within 30-40 hours and correlated well with the real-time release at 37 degrees C and pH 7.0. At the higher molecular weight, a slightly longer accelerated release time and higher temperature were required to correlate with the real-time release. The data suggest that by optimization of release conditions such as temperature, surfactant concentration, buffer component, and pH, an accelerated study could be employed to evaluate depot formulations for a given polymer type.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11741203      PMCID: PMC2761121          DOI: 10.1208/ps010307

Source DB:  PubMed          Journal:  AAPS PharmSci        ISSN: 1522-1059


  7 in total

1.  Non-invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron paramagnetic resonance spectroscopy.

Authors:  K Mader; B Gallez; K J Liu; H M Swartz
Journal:  Biomaterials       Date:  1996-02       Impact factor: 12.479

2.  One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats.

Authors:  H Okada; T Heya; Y Ogawa; T Shimamoto
Journal:  J Pharmacol Exp Ther       Date:  1988-02       Impact factor: 4.030

3.  Effect of gamma-irradiation on peptide-containing hydrophilic poly (d,l-lactide-co-glycolide) microspheres.

Authors:  M Shameem; H Lee; K Burton; B C Thanoo; P P Deluca
Journal:  PDA J Pharm Sci Technol       Date:  1999 Nov-Dec

4.  Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers.

Authors:  H Okada; Y Doken; Y Ogawa; H Toguchi
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

5.  Treatment of patients with advanced cancer of the prostate using a slow-release (depot) formulation of the LHRH agonist ICI 118630 (Zoladex).

Authors:  K J Walker; A O Turkes; A Turkes; R Zwink; C Beacock; A C Buck; W B Peeling; K Griffiths
Journal:  J Endocrinol       Date:  1984-11       Impact factor: 4.286

6.  Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

Authors:  J H Eldridge; J K Staas; J A Meulbroek; T R Tice; R M Gilley
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

7.  In vivo degradation and biocompatibility study of in vitro pre-degraded as-polymerized polyactide particles.

Authors:  J E Bergsma; F R Rozema; R R Bos; G Boering; W C de Bruijn; A J Pennings
Journal:  Biomaterials       Date:  1995-03       Impact factor: 12.479

  7 in total
  11 in total

1.  FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms.

Authors:  Martin Siewert; Jennifer Dressman; Cynthia K Brown; Vinod P Shah
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

2.  Development of a dialysis in vitro release method for biodegradable microspheres.

Authors:  Susan S D'Souza; Patrick P DeLuca
Journal:  AAPS PharmSciTech       Date:  2005-10-06       Impact factor: 3.246

3.  FIP/AAPS joint workshop report: dissolution/in vitro release testing of novel/special dosage forms.

Authors:  Cynthia K Brown; Horst Dieter Friedel; Amy R Barker; Lucinda F Buhse; Susanne Keitel; Todd L Cecil; Johannes Kraemer; J Michael Morris; Christos Reppas; Mary P Stickelmeyer; Chikako Yomota; Vinod P Shah
Journal:  AAPS PharmSciTech       Date:  2011-06-18       Impact factor: 3.246

4.  Acceleration of in vitro dissolution studies of sustained release dosage form of theophylline and in vitro-in vivo evaluations in terms of correlations.

Authors:  Gökhan Ertan; Ercüment Karasulu; Işık Ozgüney; Yeşim Karasulu; Sebnem Apaydın; Gülten Kantarcı; Aysu Yurdasiper; Mehmet Ali Ege
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-07-08       Impact factor: 2.441

5.  A short term quality control tool for biodegradable microspheres.

Authors:  Susan D'Souza; Jabar A Faraj; Rossella Dorati; Patrick P DeLuca
Journal:  AAPS PharmSciTech       Date:  2014-02-12       Impact factor: 3.246

Review 6.  Accelerated in-vitro release testing methods for extended-release parenteral dosage forms.

Authors:  Jie Shen; Diane J Burgess
Journal:  J Pharm Pharmacol       Date:  2012-03-08       Impact factor: 3.765

7.  A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres.

Authors:  Susan S D'Souza; Jabar A Faraj; Patrick P DeLuca
Journal:  AAPS PharmSciTech       Date:  2005-10-31       Impact factor: 3.246

Review 8.  In vitro dissolution considerations associated with nano drug delivery systems.

Authors:  Ritu Gupta; Yuan Chen; Huan Xie
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-06-15

Review 9.  Methods to assess in vitro drug release from injectable polymeric particulate systems.

Authors:  Susan S D'Souza; Patrick P DeLuca
Journal:  Pharm Res       Date:  2006-01-13       Impact factor: 4.580

10.  An Accelerated Release Study to Evaluate Long-Acting Contraceptive Levonorgestrel-Containing in Situ Forming Depot Systems.

Authors:  Dileep R Janagam; Lizhu Wang; Suryatheja Ananthula; James R Johnson; Tao L Lowe
Journal:  Pharmaceutics       Date:  2016-09-01       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.